PHAT Other | PHATHOM PHARMACEUTICALS, INC.

PHATHOM PHARMACEUTICALS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2026-02-26: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · PHAT · The Nasdaq Global Select Market.
2025-03-06: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · PHAT · The Nasdaq Global Select Market.
2024-11-07: Form 10-Q; Item Emerging growth company; As filed Yes.
2024-08-08: Form 10-Q; Item Emerging growth company; As filed Yes.

Filed	Form	Item	As filed
2026-02-26	10-K	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · PHAT · The Nasdaq Global Select Market
2025-03-06	10-K	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · PHAT · The Nasdaq Global Select Market
2024-11-07	10-Q	Emerging growth company	Yes
2024-08-08	10-Q	Emerging growth company	Yes
2024-06-14	10-K/A	Public float as of 2023-06-30	$526.00M
2024-06-14	10-K/A	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · PHAT · The Nasdaq Global Select Market
2024-06-14	10-K/A	Emerging growth company	Yes
2024-06-14	10-Q/A	Emerging growth company	Yes
2024-05-09	10-Q	Emerging growth company	Yes
2024-03-07	10-K	Public float as of 2023-06-30	$526.00M
2024-03-07	10-K	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · PHAT · The Nasdaq Global Select Market
2024-03-07	10-K	Emerging growth company	Yes
2023-11-09	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · Nasdaq Global Select Market
2023-11-09	10-Q	Emerging growth company	Yes
2023-08-10	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · Nasdaq Global Select Market
2023-08-10	10-Q	Emerging growth company	Yes
2023-05-10	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · Nasdaq Global Select Market
2023-05-10	10-Q	Emerging growth company	Yes
2023-02-28	10-K	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · PHAT · The Nasdaq Global Select Market
2023-02-28	10-K	Emerging growth company	Yes
2022-11-09	10-Q/A	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · Nasdaq Global Select Market
2022-11-09	10-Q/A	Emerging growth company	Yes
2022-11-08	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · Nasdaq Global Select Market
2022-11-08	10-Q	Emerging growth company	Yes
2022-08-02	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · Nasdaq Global Select Market
2022-08-02	10-Q	Emerging growth company	Yes
2022-05-10	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · Nasdaq Global Select Market
2022-05-10	10-Q	Emerging growth company	Yes
2022-03-01	10-K	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · PHAT · The Nasdaq Global Select Market
2022-03-01	10-K	Emerging growth company	Yes
2021-11-08	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · Nasdaq Global Select Market
2021-11-08	10-Q	Emerging growth company	Yes
2021-08-10	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · Nasdaq Global Select Market
2021-08-10	10-Q	Emerging growth company	Yes
2021-05-11	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · NASDAQ
2021-05-11	10-Q	Emerging growth company	Yes
2021-03-30	10-K	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · PHAT · NASDAQ
2021-03-30	10-K	Emerging growth company	Yes
2020-11-10	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · NASDAQ
2020-11-10	10-Q	Emerging growth company	Yes
2020-08-06	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · NASDAQ
2020-08-06	10-Q	Emerging growth company	Yes
2020-05-12	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · NASDAQ
2020-05-12	10-Q	Emerging growth company	Yes
2020-03-19	10-K	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · PHAT · NASDAQ
2020-03-19	10-K	Emerging growth company	Yes
2019-11-25	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · PHAT · NASDAQ
2019-11-25	10-Q	Emerging growth company	Yes
2019-11-25	10-Q	Current in its reporting	No

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82
CytomX Therapeutics, Inc. (CTMX)	United States	$0.598B	-10.25
CorMedix Inc. (CRMD)	United States	$0.605B	3.25
Aquestive Therapeutics, Inc. (AQST)	United States	$0.606B	-6.67
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47
CRESCENT BIOPHARMA, INC. (CBIO)	United States	$0.529B	-5.20
Evolus, Inc. (EOLS)	United States	$0.519B	-13.32
Neurogene Inc. (NGNE)		$0.625B	-4.46